share_log

Raymond James Maintains Outperform on AngioDynamics, Lowers Price Target to $12

Raymond James Maintains Outperform on AngioDynamics, Lowers Price Target to $12

雷蒙德·詹姆斯在AngioDynamics上保持跑赢大盘,将目标价下调至12美元
Benzinga ·  2023/10/06 04:16

Raymond James analyst Jayson Bedford maintains AngioDynamics (NASDAQ:ANGO) with a Outperform and lowers the price target from $13 to $12.

Raymond James分析师杰森·贝德福德维持AngioDynamic(纳斯达克:ANGO)的强于大盘表现,并将目标价从13美元下调至12美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发